Real-time enrollment status for this pulmonary disease, chronic obstructive clinical trial
Current Status
Recruiting
Checked: October 12, 2026 at 2:36 PM UTC
| NCT Number | NCT06961214 |
| Recruiting Status | Recruiting |
| Condition | Pulmonary Disease, Chronic Obstructive |
| Phase | PHASE3 |
| Target Enrollment | 961 participants |
| Active Locations | 57 sites in the US |
| Sponsor | GlaxoSmithKline |
| Last Updated on CT.gov | October 5, 2026 (1 week ago) |
As of October 12, 2026: Clinical trial NCT06961214 is currently recruiting participants. This phase3 study for pulmonary disease, chronic obstructive is actively seeking new participants at 57 locations across the United States. The study is sponsored by GlaxoSmithKline. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06961214 is actively recruiting participants as of October 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 57 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06961214 was last updated 1 week ago (October 5, 2026). HelloStudys verifies this status automatically.